RVMD Free Cash Flow History: $-913.7M (FY2025)

Fiscal year	Q1	Q2	Q3	Q4
FY26	−$356M−79.9%	−$390M−70.0%	Not reported	Not reported
FY25	−$198M−20.8%	−$229M−75.5%	−$211M−57.3%	−$276M−97.9%
FY24	−$164M−155.2%	−$131M−91.3%	−$134M−30.0%	−$140M−13.5%
FY23	−$64M−12.4%	−$68M−17.2%	−$103M−86.4%	−$123M−90.0%
FY22	−$57M−39.7%	−$58M−64.6%	−$55M−49.2%	−$65M−59.9%

01—History

Free Cash Flow History

Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.

−$913.7M

YoY changeLargest recent move−97.3%in FY20Latest −60.9%

1 older move runs past ±150% (largest −18153.5%); point at, tap or drag across the bars to read one.

02—Ledger

Free Cash Flow, period by period

Period	Value	Change	Source
FY2025	−$913.7M	−60.9%	10-K
FY2024	−$567.7M	−58.5%	10-K
FY2023	−$358.3M	−52.3%	10-K
FY2022	−$235.2M	−53.0%	10-K
FY2021	−$153.7M	−49.2%	10-K
FY2020	−$103.0M	−97.3%	10-K
FY2019	−$52.2M	−18153.5%	10-K
FY2018	−$286,000	—	10-K

03—Questions

What is Revolution Medicines's current free cash flow?

Revolution Medicines (RVMD) annual free cash flow for 2025 was $-913.7M, a 60.94% decline from 2024. Revolution Medicines free cash flow for the quarter ending June 30, 2026 was $-389.6M.

What was Revolution Medicines's free cash flow in 2024?

Revolution Medicines annual free cash flow for 2024 was $-567.7M, a 58.45% decline from 2023.

What was Revolution Medicines's free cash flow in 2023?

Revolution Medicines annual free cash flow for 2023 was $-358.3M, a 52.33% decline from 2022.

Company: Revolution Medicines
Ticker: RVMD
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)

Revolution Medicines Free Cash Flow 2018-2026 | RVMD

Key Statistics